Shruthi Mahalingaiah, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Polycystic Ovary Syndrome | 8 | 2024 | 370 | 3.710 |
Why?
|
Endocrine Disruptors | 7 | 2022 | 237 | 2.920 |
Why?
|
Menstrual Cycle | 8 | 2023 | 551 | 2.890 |
Why?
|
Cosmetics | 3 | 2023 | 97 | 2.100 |
Why?
|
Environmental Exposure | 16 | 2022 | 4232 | 1.720 |
Why?
|
Air Pollution | 9 | 2023 | 2286 | 1.560 |
Why?
|
Air Pollutants | 11 | 2023 | 2816 | 1.540 |
Why?
|
Menstruation Disturbances | 4 | 2022 | 148 | 1.470 |
Why?
|
Fertilization in Vitro | 7 | 2022 | 1284 | 1.430 |
Why?
|
Abortion, Spontaneous | 4 | 2019 | 544 | 1.160 |
Why?
|
Environmental Pollutants | 5 | 2022 | 1179 | 1.140 |
Why?
|
Phenols | 3 | 2019 | 497 | 1.070 |
Why?
|
Fertility | 4 | 2021 | 781 | 1.060 |
Why?
|
Malus | 2 | 2022 | 48 | 1.030 |
Why?
|
Pregnancy Rate | 3 | 2017 | 643 | 1.020 |
Why?
|
Hair Preparations | 2 | 2021 | 32 | 0.970 |
Why?
|
Menstruation | 2 | 2023 | 302 | 0.900 |
Why?
|
Tetrachloroethylene | 3 | 2020 | 6 | 0.890 |
Why?
|
Ovary | 2 | 2019 | 981 | 0.890 |
Why?
|
Ovarian Hyperstimulation Syndrome | 1 | 2022 | 53 | 0.840 |
Why?
|
Pregnancy Outcome | 6 | 2023 | 2795 | 0.770 |
Why?
|
Benzhydryl Compounds | 3 | 2019 | 845 | 0.760 |
Why?
|
Phthalic Acids | 2 | 2022 | 436 | 0.740 |
Why?
|
Hirsutism | 1 | 2020 | 69 | 0.720 |
Why?
|
Infertility, Female | 2 | 2016 | 788 | 0.700 |
Why?
|
Endometriosis | 3 | 2022 | 839 | 0.700 |
Why?
|
Water Pollutants, Chemical | 3 | 2020 | 311 | 0.660 |
Why?
|
Leiomyoma | 2 | 2014 | 730 | 0.640 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2020 | 2408 | 0.600 |
Why?
|
Ecosystem | 1 | 2021 | 474 | 0.600 |
Why?
|
Pregnancy | 22 | 2023 | 29144 | 0.590 |
Why?
|
Premature Birth | 3 | 2023 | 1721 | 0.560 |
Why?
|
Gastroesophageal Reflux | 1 | 2023 | 782 | 0.560 |
Why?
|
Metformin | 1 | 2023 | 836 | 0.560 |
Why?
|
Women's Health | 3 | 2022 | 2034 | 0.540 |
Why?
|
Nurses | 3 | 2022 | 2462 | 0.530 |
Why?
|
Metabolome | 1 | 2022 | 895 | 0.530 |
Why?
|
Menarche | 1 | 2018 | 516 | 0.510 |
Why?
|
Gastrointestinal Diseases | 1 | 2023 | 1170 | 0.510 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2015 | 115 | 0.510 |
Why?
|
Reproduction | 2 | 2018 | 668 | 0.510 |
Why?
|
Uterine Neoplasms | 2 | 2014 | 1513 | 0.490 |
Why?
|
Female | 54 | 2024 | 380193 | 0.470 |
Why?
|
Metabolomics | 1 | 2022 | 1485 | 0.460 |
Why?
|
Menopause | 3 | 2021 | 1626 | 0.460 |
Why?
|
Diethylstilbestrol | 1 | 2013 | 93 | 0.460 |
Why?
|
Infertility | 1 | 2020 | 655 | 0.460 |
Why?
|
Vehicle Emissions | 2 | 2017 | 665 | 0.450 |
Why?
|
Fetal Development | 1 | 2019 | 767 | 0.450 |
Why?
|
Particulate Matter | 7 | 2023 | 2529 | 0.440 |
Why?
|
Maternal Exposure | 2 | 2016 | 961 | 0.420 |
Why?
|
Plastics | 1 | 2012 | 123 | 0.410 |
Why?
|
Ovulation | 2 | 2023 | 189 | 0.400 |
Why?
|
Culture Media | 1 | 2012 | 909 | 0.370 |
Why?
|
Pilot Projects | 5 | 2023 | 8319 | 0.360 |
Why?
|
Electronic Health Records | 2 | 2024 | 4468 | 0.330 |
Why?
|
Humans | 54 | 2024 | 744366 | 0.320 |
Why?
|
Luteinizing Hormone | 3 | 2024 | 869 | 0.280 |
Why?
|
Preconception Care | 2 | 2017 | 134 | 0.270 |
Why?
|
Adult | 27 | 2023 | 214052 | 0.260 |
Why?
|
Anti-Mullerian Hormone | 3 | 2022 | 402 | 0.250 |
Why?
|
North America | 2 | 2020 | 1249 | 0.250 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2725 | 0.240 |
Why?
|
Placenta Diseases | 2 | 2017 | 199 | 0.230 |
Why?
|
Soaps | 1 | 2023 | 28 | 0.230 |
Why?
|
Educational Status | 1 | 2011 | 2540 | 0.220 |
Why?
|
Menorrhagia | 1 | 2022 | 63 | 0.210 |
Why?
|
Contraceptive Agents | 1 | 2023 | 151 | 0.210 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2022 | 113 | 0.200 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 11726 | 0.200 |
Why?
|
Hazardous Substances | 1 | 2022 | 149 | 0.200 |
Why?
|
Oils | 1 | 2021 | 63 | 0.200 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2023 | 340 | 0.190 |
Why?
|
Fertilization | 1 | 2022 | 196 | 0.190 |
Why?
|
Proportional Hazards Models | 5 | 2021 | 12356 | 0.190 |
Why?
|
Ovulation Induction | 1 | 2022 | 274 | 0.190 |
Why?
|
Progestins | 1 | 2022 | 306 | 0.190 |
Why?
|
Chorionic Gonadotropin | 1 | 2022 | 476 | 0.180 |
Why?
|
Oocyte Retrieval | 1 | 2021 | 161 | 0.180 |
Why?
|
Ultraviolet Rays | 2 | 2022 | 1060 | 0.180 |
Why?
|
Endometrium | 1 | 2022 | 424 | 0.170 |
Why?
|
Young Adult | 9 | 2023 | 56429 | 0.170 |
Why?
|
Patient Selection | 1 | 2011 | 4216 | 0.170 |
Why?
|
Self Report | 2 | 2020 | 3553 | 0.160 |
Why?
|
New York | 1 | 2021 | 886 | 0.160 |
Why?
|
Chromatography, Liquid | 1 | 2022 | 976 | 0.160 |
Why?
|
Infant, Low Birth Weight | 1 | 2023 | 850 | 0.160 |
Why?
|
Prospective Studies | 8 | 2022 | 53290 | 0.160 |
Why?
|
Embryo Transfer | 1 | 2022 | 510 | 0.160 |
Why?
|
Cohort Studies | 10 | 2022 | 40559 | 0.160 |
Why?
|
Seasons | 1 | 2023 | 1493 | 0.150 |
Why?
|
Boston | 5 | 2021 | 9312 | 0.150 |
Why?
|
Acetaminophen | 1 | 2021 | 545 | 0.150 |
Why?
|
Infant, Newborn | 5 | 2023 | 25628 | 0.150 |
Why?
|
Cryopreservation | 1 | 2022 | 670 | 0.150 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15160 | 0.140 |
Why?
|
Adolescent | 8 | 2023 | 85779 | 0.140 |
Why?
|
Oocytes | 1 | 2022 | 1188 | 0.140 |
Why?
|
Progesterone | 1 | 2021 | 775 | 0.140 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25039 | 0.140 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2022 | 1206 | 0.140 |
Why?
|
Residence Characteristics | 2 | 2017 | 2050 | 0.140 |
Why?
|
Health Surveys | 2 | 2017 | 4036 | 0.140 |
Why?
|
Stillbirth | 2 | 2017 | 346 | 0.130 |
Why?
|
Longevity | 1 | 2022 | 1071 | 0.130 |
Why?
|
Mass Spectrometry | 1 | 2022 | 2204 | 0.130 |
Why?
|
Birth Weight | 1 | 2023 | 2069 | 0.120 |
Why?
|
Massachusetts | 5 | 2021 | 8662 | 0.120 |
Why?
|
United States | 7 | 2021 | 69872 | 0.120 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2029 | 0.120 |
Why?
|
ROC Curve | 1 | 2022 | 3528 | 0.120 |
Why?
|
Estrogens | 1 | 2021 | 1566 | 0.120 |
Why?
|
Canada | 2 | 2016 | 2065 | 0.120 |
Why?
|
Retrospective Studies | 7 | 2024 | 77460 | 0.120 |
Why?
|
Ectogenesis | 1 | 2012 | 8 | 0.110 |
Why?
|
Prolactin | 2 | 2021 | 669 | 0.110 |
Why?
|
Patient Compliance | 2 | 2015 | 2684 | 0.110 |
Why?
|
Embryo Implantation | 2 | 2011 | 272 | 0.110 |
Why?
|
Forecasting | 1 | 2022 | 2951 | 0.110 |
Why?
|
Counseling | 1 | 2020 | 1523 | 0.110 |
Why?
|
Logistic Models | 2 | 2022 | 13409 | 0.110 |
Why?
|
Bariatric Surgery | 1 | 2022 | 952 | 0.110 |
Why?
|
Age Factors | 2 | 2022 | 18373 | 0.100 |
Why?
|
DDT | 1 | 2011 | 31 | 0.100 |
Why?
|
Bone Remodeling | 1 | 2015 | 575 | 0.100 |
Why?
|
Hexachlorobenzene | 1 | 2011 | 30 | 0.100 |
Why?
|
Limit of Detection | 1 | 2012 | 265 | 0.100 |
Why?
|
Caffeine | 1 | 2016 | 699 | 0.100 |
Why?
|
Particle Size | 1 | 2016 | 1642 | 0.100 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2011 | 88 | 0.100 |
Why?
|
Suction | 1 | 2012 | 267 | 0.100 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 277 | 0.100 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 2873 | 0.100 |
Why?
|
Incidence | 4 | 2020 | 20952 | 0.100 |
Why?
|
Solubility | 1 | 2012 | 1088 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2213 | 0.090 |
Why?
|
Drug Design | 1 | 2015 | 1076 | 0.090 |
Why?
|
Hormone Replacement Therapy | 1 | 2015 | 745 | 0.090 |
Why?
|
Age of Onset | 1 | 2016 | 3270 | 0.090 |
Why?
|
Pregnancy Trimester, First | 1 | 2013 | 853 | 0.090 |
Why?
|
Time Factors | 4 | 2020 | 40075 | 0.090 |
Why?
|
Follicle Stimulating Hormone | 2 | 2022 | 744 | 0.080 |
Why?
|
Animals | 7 | 2023 | 168768 | 0.080 |
Why?
|
Polychlorinated Biphenyls | 1 | 2011 | 245 | 0.080 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13991 | 0.080 |
Why?
|
Internet | 1 | 2021 | 3056 | 0.080 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1572 | 0.080 |
Why?
|
United States Food and Drug Administration | 1 | 2016 | 1584 | 0.080 |
Why?
|
Androgens | 1 | 2015 | 1281 | 0.080 |
Why?
|
Environmental Monitoring | 1 | 2014 | 1414 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 9955 | 0.070 |
Why?
|
Regression Analysis | 1 | 2016 | 6459 | 0.070 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1157 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2016 | 19905 | 0.070 |
Why?
|
Risk Factors | 5 | 2021 | 72296 | 0.070 |
Why?
|
Comprehension | 1 | 2011 | 610 | 0.070 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39052 | 0.070 |
Why?
|
T-Box Domain Proteins | 1 | 2008 | 471 | 0.070 |
Why?
|
Macaca mulatta | 2 | 2022 | 2377 | 0.060 |
Why?
|
Middle Aged | 6 | 2021 | 213390 | 0.060 |
Why?
|
Male | 10 | 2023 | 350115 | 0.060 |
Why?
|
Life Style | 1 | 2015 | 3835 | 0.060 |
Why?
|
Algorithms | 1 | 2024 | 13882 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9145 | 0.060 |
Why?
|
Body Mass Index | 1 | 2020 | 12721 | 0.050 |
Why?
|
Risk Assessment | 2 | 2016 | 23336 | 0.050 |
Why?
|
Benzene | 1 | 2022 | 100 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12244 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8385 | 0.050 |
Why?
|
Follicular Fluid | 1 | 2021 | 87 | 0.050 |
Why?
|
Sperm Count | 1 | 2022 | 216 | 0.050 |
Why?
|
Formaldehyde | 1 | 2022 | 353 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2278 | 0.050 |
Why?
|
Linear Models | 1 | 2011 | 5953 | 0.050 |
Why?
|
Child | 3 | 2018 | 77709 | 0.050 |
Why?
|
Sperm Motility | 1 | 2022 | 253 | 0.050 |
Why?
|
Semen Analysis | 1 | 2022 | 204 | 0.050 |
Why?
|
Perioperative Period | 1 | 2021 | 256 | 0.040 |
Why?
|
Semen | 1 | 2022 | 316 | 0.040 |
Why?
|
Periodicity | 1 | 2021 | 364 | 0.040 |
Why?
|
Testis | 1 | 2022 | 804 | 0.040 |
Why?
|
Cognition | 1 | 2015 | 6770 | 0.040 |
Why?
|
Thyrotropin | 1 | 2021 | 849 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2011 | 2861 | 0.040 |
Why?
|
Placebos | 1 | 2021 | 1676 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 3922 | 0.030 |
Why?
|
Abruptio Placentae | 1 | 2017 | 118 | 0.030 |
Why?
|
Uterine Hemorrhage | 1 | 2017 | 255 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 4386 | 0.030 |
Why?
|
Infant, Small for Gestational Age | 1 | 2017 | 440 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2307 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1699 | 0.030 |
Why?
|
Quality of Life | 1 | 2015 | 12802 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2011 | 21748 | 0.030 |
Why?
|
Demography | 1 | 2018 | 1655 | 0.030 |
Why?
|
Vitamins | 1 | 2021 | 1623 | 0.030 |
Why?
|
Gestational Age | 1 | 2021 | 3493 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14723 | 0.030 |
Why?
|
Pain Measurement | 1 | 2021 | 3420 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1643 | 0.020 |
Why?
|
Testosterone | 1 | 2022 | 2419 | 0.020 |
Why?
|
Beverages | 1 | 2016 | 821 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 12073 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2011 | 980 | 0.020 |
Why?
|
Obesity | 2 | 2022 | 12746 | 0.020 |
Why?
|
Pre-Eclampsia | 1 | 2017 | 1200 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2008 | 370 | 0.020 |
Why?
|
STAT5 Transcription Factor | 1 | 2008 | 259 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12025 | 0.020 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 175 | 0.020 |
Why?
|
Janus Kinase 2 | 1 | 2008 | 528 | 0.020 |
Why?
|
Signal Transduction | 1 | 2008 | 23404 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2011 | 63107 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2008 | 794 | 0.020 |
Why?
|
Comorbidity | 1 | 2018 | 10388 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7730 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3589 | 0.010 |
Why?
|
Research Design | 1 | 2018 | 5984 | 0.010 |
Why?
|
Infant | 1 | 2023 | 35134 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15221 | 0.010 |
Why?
|
Smoking | 1 | 2018 | 8987 | 0.010 |
Why?
|
Blotting, Western | 1 | 2008 | 5181 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2008 | 6386 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 41005 | 0.010 |
Why?
|
Cell Line | 1 | 2008 | 16000 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 57776 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 19233 | 0.010 |
Why?
|
Aged | 1 | 2018 | 163288 | 0.000 |
Why?
|
Mice | 1 | 2008 | 81201 | 0.000 |
Why?
|